Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina.
It has been demonstrated in animal experiments that heparin accelerates the coronary collateral development induced by repeated coronary occlusion. We used this effect of heparin for the treatment of patients with stable effort angina. In 10 patients, treadmill exercise was performed according to standard Bruce protocol twice a day for 10 days. A single intravenous dose of heparin (5000 IU) was given 10 to 20 min before each exercise period. Exercise with heparin pretreatment increased the total exercise duration from 6.3 +/- 1.9 (SD) to 9.1 +/- 2.2 min (p less than .001) and the maximal double product (DP) from 18,900 +/- 5100 to 25,500 +/- 6800 mm Hg.beats/min (p less than .001). The DP at the onset of angina was also increased by 35% (p less than .01) and the DP at which ST depression (0.1 mV) first appeared was 19% (p less than .05) greater after treatment. Repeat coronary cineangiography revealed an increase in the extent of opacification of collaterals to the jeopardized myocardium. In an additional six patients, treadmill exercise was performed with no medication twice a day for 10 days. All of the above-mentioned variables of treadmill capacity remained unchanged, despite 20 exercise periods without heparin pretreatment. Thus, heparin accelerates exercise-induced coronary collateral development by promoting angiogenesis. The development of such a therapeutic modality will open a new field for the treatment of patients with ischemia.
Fujita
M
M
Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.
Sasayama
S
S
Asanoi
H
H
Nakajima
H
H
Sakai
O
O
Ohno
A
A
D000787:Angina Pectoris / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D002933:Cineradiography; D003097:Collateral Circulation / Q000187:drug effects*; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D004341:Drug Evaluation; D005080:Exercise Test; D005081:Exercise Therapy / Q000379:methods*; D005260:Female; D006352:Heart Ventricles / Q000000981:diagnostic imaging; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D005082:Physical Exertion; D011877:Radionuclide Imaging; D011897:Random Allocation; D013670:Sodium Pertechnetate Tc 99m; D013997:Time Factors
D006493:Heparin; D013670:Sodium Pertechnetate Tc 99m